0.523
price down icon12.82%   -0.0769
after-market  After Hours:  1.50  0.977   +186.81%
loading
Novo Integrated Sciences Inc stock is currently priced at $0.523, with a 24-hour trading volume of 1.53M. It has seen a -12.82% decreased in the last 24 hours and a +11.68% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $0.5933 pivot point. If it approaches the $0.5133 support level, significant changes may occur.
Previous Close:
$0.5999
Open:
$0.63
24h Volume:
1.53M
Market Cap:
$9.97M
Revenue:
$13.04M
Net Income/Loss:
$-13.96M
P/E Ratio:
-0.5505
EPS:
-0.95
Net Cash Flow:
$-4.12M
1W Performance:
+0.77%
1M Performance:
+11.68%
6M Performance:
+75.50%
1Y Performance:
+264.97%
1D Range:
Value
$0.52
$0.63
52W Range:
Value
$0.069
$2.2299

Novo Integrated Sciences Inc Stock (NVOS) Company Profile

Name
Name
Novo Integrated Sciences Inc
Name
Phone
206 617 9797
Name
Address
11120 NE 2nd Street, Suite 100, Bellevue
Name
Employee
73
Name
Twitter
Name
Next Earnings Date
2023-07-12
Name
Latest SEC Filings
Name
NVOS's Discussions on Twitter

Novo Integrated Sciences Inc Stock (NVOS) Financials Data

Novo Integrated Sciences Inc (NVOS) Revenue 2024

NVOS reported a revenue (TTM) of $13.04 million for the quarter ending November 30, 2023, a +8.74% rise year-over-year.
loading

Novo Integrated Sciences Inc (NVOS) Net Income 2024

NVOS net income (TTM) was -$13.96 million for the quarter ending November 30, 2023, a +60.09% increase year-over-year.
loading

Novo Integrated Sciences Inc (NVOS) Cash Flow 2024

NVOS recorded a free cash flow (TTM) of -$4.12 million for the quarter ending November 30, 2023, a +24.77% increase year-over-year.
loading

Novo Integrated Sciences Inc (NVOS) Earnings per Share 2024

NVOS earnings per share (TTM) was -$1.08 for the quarter ending November 30, 2023, a +90.80% growth year-over-year.
loading
Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community based home care physiotherapy, community based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates 16 owned clinics. The company was incorporated in 2000 and is based in Bellevue, Washington. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc.
$29.81
price down icon 0.27%
$66.12
price down icon 0.91%
$116.89
price up icon 0.29%
medical_care_facilities EHC
$83.21
price down icon 0.25%
medical_care_facilities CHE
$561.65
price up icon 0.36%
medical_care_facilities UHS
$167.70
price down icon 1.29%
Cap:     |  Volume (24h):